However, recent developments underscore the need for careful refinement of CD19-targeted approaches: some CD19 CAR T cells have been linked to severe or fatal cardiac events, whereas CD19/CD3 bispecific T-cell engagers can induce fatal hypotension in pediatric ALL 14. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.